Phthalimide

Phthalimide

SCHEMBL443473

O=C1NC(=O)c2ccccc21.[Na]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 1/20 0.94
▸ CASP7 P55210 3/20 0.75
▸ CASP3 P42574 2/20 0.75
▸ CASP6 P55212 2/20 0.75
▸ CASP8 Q14790 2/20 0.75
▸ CASP2 P42575 1/20 0.75
▸ PARP1 P09874 4/20 0.56
▸ PDGFRA P16234 1/20 0.56
▸ FER P16591 1/20 0.56
▸ LTK P29376 1/20 0.56
▸ CDK8 P49336 1/20 0.56
▸ ACVR1 Q04771 1/20 0.56
▸ LRRK2 Q5S007 1/20 0.56
▸ DYRK1B Q9Y463 1/20 0.56
▸ MAPK1 P28482 4/20 0.52
▸ LMNA P02545 3/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ MAOA P21397 5/20 0.50
▸ MAOB P27338 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalimide SCHEMBL29375124 1.00 GSK3B (0.94) GSK3BCASP7CASP3CASP6CASP8
Phthalimide SCHEMBL11040503 0.97 GSK3B (1.00) GSK3BCASP7CASP3CASP6CASP8
Phthalimide SCHEMBL30125197 0.97 GSK3B (1.00) GSK3BCASP7CASP3CASP6CASP8
Phthalimide SCHEMBL29366030 0.97 GSK3B (1.00) GSK3BCASP7CASP3CASP6CASP8
Phthalimide SCHEMBL64 0.97 GSK3B (1.00) GSK3BCASP7CASP3CASP6CASP8
Phthalimide SCHEMBL10192661 0.97 GSK3B (1.00) GSK3BCASP7CASP3CASP6CASP8
Phthalimide SCHEMBL7771670 0.97 GSK3B (1.00) GSK3BCASP7CASP3CASP6CASP8
Phthalimide SCHEMBL4297661 0.94 GSK3B (0.94) GSK3BCASP7CASP3CASP6CASP8
Phthalimide SCHEMBL7521027 0.94 GSK3B (0.94) GSK3BCASP7CASP3CASP6CASP8
Phthalimide SCHEMBL543800 0.94 GSK3B (0.94) GSK3BCASP7CASP3CASP6CASP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250115585-A1 METHOD FOR PRODUCING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-04-10 — — US claimed
CN-119330870-A Synthesis method of N-cyclohexyl thio-phthalic acid amide 山东鑫生工贸有限公司 2025-01-21 — — CN claimed
CN-119039201-A Synthesis method of (S) -1-tert-butoxycarbonyl-3-aminopyrrolidine 苏州汉德创宏生化科技有限公司 2024-11-29 — — CN claimed
CN-118762939-A Preparation and application of low-cost oxygen/nitrogen co-doped self-activated porous carbon nano sheet composite electrode material 重庆市潼南区生态环境监测站 2024-10-11 — — CN claimed
CN-117986213-A Method for preparing 2, 5-di (aminomethyl) furan from 5-chloromethyl furfural 厦门大学 2024-05-07 — — CN claimed
EP-4353718-A1 METHOD FOR PRODUCING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-04-17 — — EP claimed
CN-117486758-A Preparation method of (1S, 3S) -3-aminocycloamyl carbamic acid tert-butyl ester 南京正济医药研究有限公司 2024-02-02 — — CN claimed
CN-117460727-A Process for producing dihydropyridazine-3, 5-dione derivative 中外制药株式会社 2024-01-26 — — CN claimed
CN-117285560-A Cathode interface layer material, preparation method and application thereof 浙江爱旭太阳能科技有限公司 2023-12-26 — — CN claimed
CN-116926632-A Nickel electroplating liquid, preparation method and application thereof 信维电子科技(益阳)有限公司 2023-10-24 — — CN claimed
WO-2009128088-A2 PREPARATION OF 2-(2-ALKOXY PHENOXY) ETHYLAMINE, AN INTERMEDIATE OF CARVEDILOL AND TAMSULOSIN SHODHANA LABORATORIES LIMITED (IN) 2009-10-22 — — WO claimed
CN-100480868-C Electronic photographic photosensitive material, electronic photographic photoelectric conductor and making method thereof FUJI MOTOR PHOTO APPLIANCES CO (JP) 2009-04-22 — — CN claimed
WO-2007058630-A1 NOVEL BIS(AMINO)-ORTHO-DICARBABORANE CLUSTER COMPOUNDS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2007-05-24 — — WO claimed
US-6613488-B1 Metal-free- or titanyloxy- phthalocyanine compound and phthalimide salt FUJI ELECTRIC IMAGING DEVICES CO., LTD. (JP) 2003-09-02 — — US claimed
CN-1296198-A Electronic photographic photosensitive material, electronic photographic photoelectric conductor and making method thereof FUJI MOTOR PHOTO APPLIANCES CO (JP) 2001-05-23 — — CN claimed
EP-0446913-B1 Process for the preparation of chlorothiazole derivatives TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-06-04 — — EP claimed
CN-1022484-C Preparation method of rubber scorch retarder ORGANIC AID AGENT FACTORY ZHAO (CN) 1993-10-20 — — CN claimed
US-5180833-A PROCESS FOR THE PREPARATION OF CHLOROTHIAZOLE DERIVATIVES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-01-19 — — US claimed
CN-1063695-A Preparation method of rubber scorch retarder ORGANIC AID AGENT FACTORY ZHAO (CN) 1992-08-19 — — CN claimed
EP-0446913-A1 Process for the preparation of chlorothiazole derivatives Takeda Chemical Industries, Ltd. (JP) 1991-09-18 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250115585-A1 METHOD FOR PRODUCING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE QDPR, DHPS, DPYD GSK3B 3830/4885CASP7 238/4885CASP3 1192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback